Literature DB >> 19009748

Types of diabetic macular edema assessed by optical coherence tomography.

Desislava N Koleva-Georgieva1, Nelly P Sivkova.   

Abstract

AIM: To assess the types of diabetic macular edema (DME) in patients with type 2 diabetes mellitus by analyzing retinal thickness, morphology and presence of macular traction using optical coherence tomography (OCT). PATIENTS AND METHODS: This prospective study included 74 diabetics with diabetic retinopathy (DR) (141 eyes), 29 diabetics without DR (57 eyes) and 25 healthy volunteers (39 eyes). The ophthalmic examination included best corrected visual acuity, stereo-ophthalmoscopy, fluorescein angiography and OCT. DME assessment was based on the analysis of several OCT features: macular thickness, retinal morphology and presence of macular traction--vitreomacular and/or from epiretinal membranes. Four OCT types of DME were suggested: type 1--early, type 2--simple, type 3--cystoid (3a--mild, 3b--intermediate, 3c--severe) and type 4--serous macular detachment. The distribution of the DME types and their correlation with retinal thickness and visual acuity were analyzed.
RESULTS: The distribution of eyes with DME was: type 1--14.1%, type 2--30.4%, type 3--45.7% (3a--14.1%, 3b--12%, 3c--19.6%) and type 4--9.8%. Macular traction with retinal distortion was detected in 31.5% of the eyes with DME. Retinal thickness at the fixation point was 176 +/- 16.8 microm (116 microm / 210 microm) in healthy eyes and 182.2 +/- 19.6 microm (138 microm / 212 microm) in eyes without DR. There was no statistically significant difference between the two groups (Independent samples test, P > 0.05). The retina was significantly thicker in eyes with early DME (232.9 +/- 7.9 microm) than in healthy eyes and eyes without DR (Independent samples test, F = 16.274 and F = 13.100, P < 0.0001). Increasing retinal thickness was significantly correlated with worse visual acuity (ANOVA, F = 16.692, P < 0.0001).
CONCLUSION: OCT precisely differentiated 4 types of DME: early, simple, cystoid and serous macular detachment, as well as determined the presence of macular traction. The early diagnosis, high precision in retinal thickness measurement, assessment of the morphologic types and macular traction are of uppermost importance in determining the therapeutic approach, prognosis and the effect of treatment.

Entities:  

Mesh:

Year:  2008        PMID: 19009748

Source DB:  PubMed          Journal:  Folia Med (Plovdiv)        ISSN: 0204-8043


  9 in total

Review 1.  Imaging and Biomarkers in Diabetic Macular Edema and Diabetic Retinopathy.

Authors:  Changyow C Kwan; Amani A Fawzi
Journal:  Curr Diab Rep       Date:  2019-08-31       Impact factor: 4.810

2.  Correlation of morphological pattern of optical coherence tomography in diabetic macular edema with systemic risk factors in middle aged males.

Authors:  Sambuddha Ghosh; Preeti Bansal; Harsha Shejao; Raghuraj Hegde; Debesh Roy; Shyamapada Biswas
Journal:  Int Ophthalmol       Date:  2014-03-01       Impact factor: 2.031

Review 3.  Updates in the management of diabetic macular edema.

Authors:  Christopher Mathew; Anastasia Yunirakasiwi; Srinivasan Sanjay
Journal:  J Diabetes Res       Date:  2015-04-23       Impact factor: 4.011

4.  Diabetic maculopathy: multicolour and SD-OCT versus fundus photography.

Authors:  Obaid Kousha; Martina Maria Delle Fave; Mariano Cozzi; Elisa Carini; Sergio Pagliarini
Journal:  BMJ Open Ophthalmol       Date:  2021-02-19

Review 5.  The Role of Intravitreal Corticosteroids in the Treatment of DME: Predictive OCT Biomarkers.

Authors:  Marion R Munk; Gabor Mark Somfai; Marc D de Smet; Guy Donati; Marcel N Menke; Justus G Garweg; Lala Ceklic
Journal:  Int J Mol Sci       Date:  2022-07-08       Impact factor: 6.208

Review 6.  Idiopathic vitreomacular traction and macular hole: a comprehensive review of pathophysiology, diagnosis, and treatment.

Authors:  D H W Steel; A J Lotery
Journal:  Eye (Lond)       Date:  2013-10       Impact factor: 3.775

7.  Optical coherence tomography classification of diabetic cystoid macular edema.

Authors:  Yasser M Helmy; Heba R Atta Allah
Journal:  Clin Ophthalmol       Date:  2013-08-28

Review 8.  The diagnostic function of OCT in diabetic maculopathy.

Authors:  Bartosz L Sikorski; Grazyna Malukiewicz; Joanna Stafiej; Hanna Lesiewska-Junk; Dorota Raczynska
Journal:  Mediators Inflamm       Date:  2013-11-28       Impact factor: 4.711

9.  Clinical Outcomes of a Treat and Extend Regimen with Intravitreal Aflibercept Injections in Patients with Diabetic Macular Edema: Experience in Clinical Practice.

Authors:  Beverley A Curry; Paul G Sanfilippo; Sarah Chan; Alexander W Hewitt; Nitin Verma
Journal:  Ophthalmol Ther       Date:  2019-11-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.